Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.

Waksal, who is not a medical doctor, imported the veterinary drug along with other “unapproved ingredients” from Colombia.

Autolus Therapeutics, a UCL spinout company, has received authorisation from the UK Medicines and Healthcare products ...

By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, ...

The United States has seen an impressive drop in cigarette smoking over the past several decades, a shift that holds ...

Cigna recently changed its policies to cover a popular breast cancer reconstruction treatment that had long been denied.

The Department of Health and Human Services announced this week that it would work to remove some artificial dyes from the ...

St. Pete doctor credits “Patient No More Series” for insurer’s change in policy for popular breast cancer surgery.

When Michelle Gidion first noticed the blue bruises dotted across her lower legs, she put them down to the family dog bashing ...

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...